skip to main content
Idioma:
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy

Bonanno, L. ; Costa, C. ; Majem, M. ; Favaretto, A. ; Rugge, M. ; Rosell, R.

Annals of oncology, 2013-04, Vol.24 (4), p.1130-1132 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study

Gridelli, C. ; Morgillo, F. ; Favaretto, A. ; de Marinis, F. ; Chella, A. ; Cerea, G. ; Mattioli, R. ; Tortora, G. ; Rossi, A. ; Fasano, M. ; Pasello, G. ; Ricciardi, S. ; Maione, P. ; Di Maio, M. ; Ciardiello, F.

Annals of oncology, 2011-07, Vol.22 (7), p.1528-1534 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Compliance to diagnostic and therapeutic pathways and innovative drug recommendations in advanced non-small cell lung cancer: preliminary results from the MOST study
Compliance to diagnostic and therapeutic pathways and innovative drug recommendations in advanced non-small cell lung cancer: preliminary results from the MOST study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Compliance to diagnostic and therapeutic pathways and innovative drug recommendations in advanced non-small cell lung cancer: preliminary results from the MOST study

Pasello, G. ; Vicario, G. ; Gori, S. ; Zustovich, F. ; Bonetti, A. ; Rosetti, F. ; Favaretto, A. ; Oniga, F. ; Bria, E. ; Toso, S. ; Boccalon, M. ; Oliani, C. ; Palazzolo, G. ; Frega, S. ; Basso, M. ; Pertile, P. ; Bortolami, A. ; Verrienti, R. ; Scanni, R. ; Conte, P.

Annals of oncology, 2017-10, Vol.28, p.vi57-vi57 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Negative prognostic factors and resulting clinical outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) included in the Italian nivolumab expanded access program (EAP)
Negative prognostic factors and resulting clinical outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) included in the Italian nivolumab expanded access program (EAP)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Negative prognostic factors and resulting clinical outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) included in the Italian nivolumab expanded access program (EAP)

Bracarda, S. ; Galli, L. ; Maruzzo, M. ; Lo Re, G. ; Buti, S. ; Favaretto, A. ; Costanzo, F.D. ; Sacco, C. ; Merlano, M. ; Mucciarini, C. ; Zafarana, E. ; Romito, S. ; Maestri, A. ; Giannitto Giorgio, C. ; Ionta, M.T. ; Turci, D. ; De Giorgi, U. ; Procopio, G. ; Cortesi, E. ; Porta, C.

Annals of oncology, 2017-09, Vol.28, p.v314-v314 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Are PubMed alone and English literature only enough for a meta-analysis?
Are PubMed alone and English literature only enough for a meta-analysis?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Are PubMed alone and English literature only enough for a meta-analysis?

Zheng, B. ; Zheng, W. ; Zhu, Y. ; Guo, C. ; Wu, W. ; Chen, C.

Annals of oncology, 2013-04, Vol.24 (4), p.1130-1130 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Symptomatic Toxicities Experienced During Anti-Cancer Treatment: Comparison of Patients' and Physicians' Reporting in Three Randomized Controlled Trials (Rcts)
Symptomatic Toxicities Experienced During Anti-Cancer Treatment: Comparison of Patients' and Physicians' Reporting in Three Randomized Controlled Trials (Rcts)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Symptomatic Toxicities Experienced During Anti-Cancer Treatment: Comparison of Patients' and Physicians' Reporting in Three Randomized Controlled Trials (Rcts)

Di Maio, M. ; Piccirillo, M.C. ; Daniele, G. ; Nuzzo, F. ; Gridelli, C. ; Gebbia, V. ; Ciardiello, F. ; De Placido, S. ; Ceribelli, A. ; Favaretto, A. ; De Matteis, A. ; Feld, R. ; Butts, C.A. ; Leighl, N.B. ; Morabito, A. ; Bryce, J. ; Signoriello, S. ; Gallo, C. ; Perrone, F.

Annals of oncology, 2014-09, Vol.25, p.iv517 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
Epidermal Growth Factor Receptor (Egfr) and Abcg2 Polymorphisms and Treatment Outcome in the Randomized Phase III Torch Trial in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients
Epidermal Growth Factor Receptor (Egfr) and Abcg2 Polymorphisms and Treatment Outcome in the Randomized Phase III Torch Trial in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Epidermal Growth Factor Receptor (Egfr) and Abcg2 Polymorphisms and Treatment Outcome in the Randomized Phase III Torch Trial in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients

Liu, G. ; Di Maio, M. ; Tsao, M. ; Cheng, D. ; Chen, Z. ; Wierzbicki, R. ; Riccardi, F. ; Spatafora, M. ; Adamo, V. ; Favaretto, A. ; Bianco, R. ; Gregg, R.W. ; Costanzo, R. ; Signoriello, S. ; Butts, C.A. ; Ciardiello, F. ; Feld, R. ; Gallo, C. ; Gridelli, C. ; Perrone, F.

Annals of oncology, 2014-09, Vol.25, p.iv438 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trial
A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trial

Daniele, G. ; Morabito, A. ; Favaretto, A. ; Filipazzi, V. ; Rossi, A. ; Gebbia, V. ; Castiglione, F. ; Cavanna, L. ; Maiello, E. ; Valmadre, G. ; Costanzo, R. ; Manzo, A. ; Bonanno, L. ; Piazza, E. ; Maione, P. ; Mancuso, G. ; Di Maio, M. ; Piccirillo, M.C. ; Gallo, C. ; Perrone, F. ; Gridelli, C.

Annals of oncology, 2015-10, Vol.26, p.vi73 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
The Relationship Between Egfr and Kras Mutation Status and Overall Survival (Os) in the Ncic Ctg Br.26 Randomized Trial of Dacomitinib (D) Versus Placebo (P) in Patients with Previously Treated Non Small Cell Lung Cancer (Nsclc)
The Relationship Between Egfr and Kras Mutation Status and Overall Survival (Os) in the Ncic Ctg Br.26 Randomized Trial of Dacomitinib (D) Versus Placebo (P) in Patients with Previously Treated Non Small Cell Lung Cancer (Nsclc)
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Relationship Between Egfr and Kras Mutation Status and Overall Survival (Os) in the Ncic Ctg Br.26 Randomized Trial of Dacomitinib (D) Versus Placebo (P) in Patients with Previously Treated Non Small Cell Lung Cancer (Nsclc)

Ellis, P.M. ; Liu, G. ; Millward, M. ; Perrone, F. ; Shepherd, F. ; Seymour, L. ; Sun, S. ; Cho, B. ; Morabito, A. ; Stockler, M.R. ; Leighl, N.B. ; Lee, C. ; Wierzbicki, R. ; Favaretto, A. ; Tsao, M. ; Wilson, C.F. ; Taylor, I. ; Ding, K. ; Goss, G. ; Bradbury, P.A.

Annals of oncology, 2014-09, Vol.25, p.iv462 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
The Predictive Role of the 53BP1 Pathway in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients (P) Treated with First-Line Platinum-Based Chemotherapy
The Predictive Role of the 53BP1 Pathway in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients (P) Treated with First-Line Platinum-Based Chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Predictive Role of the 53BP1 Pathway in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients (P) Treated with First-Line Platinum-Based Chemotherapy

Bonanno, L. ; Costa, C. ; Majem, M. ; Gimenez-Capitan, A. ; Rodriguez, I. ; Sánchez, J.J. ; Sureda, B. Massuti ; Favaretto, A. ; Rugge, M. ; Rosell, R.

Annals of oncology, 2012-09, Vol.23, p.ix533 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.